Daily non-political popular news in brief.

Long-term cancer risk follows stem cell transplant recipients

Hematopoietic stem cell transplant (HSCT) recipients face a significant long-term risk for developing a second cancer, particularly if they were older at the time of transplant or received stem cells from a female donor, according to a new study.

Read more »

Keywords: long-term, cancer, risk, follows, stem, cell, transplant, recipients, long, term, follow, recipient

« Previous | Next »

Similar news on "Long-term cancer risk follows stem cell transplant recipients":

1. Sexual function affected by stem cell transplant according to long-term study
   09-18-2007 · EurekAlert!
   A long-term study found that a type of stem cell transplant used for patients with life-threatening diseases results in decreased sexual function and activity for recipients. Further, males are likely to recover from these changes over time, while the sexuality of female patients remains compromised. In addition, neither male nor female long-term cancer survivors regained levels of sexual activity and function equal to those of their peers who have not had cancer.
   Similar news · Read more »
   
2. Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma
   12-10-2007 · EurekAlert!
   Treating relapsed follicular lymphoma patients with a milder chemotherapy regimen before they receive a blood stem cell transplant from a donor resulted in long-term complete remission for 45 of 47 patients in a clinical trial, researchers at the University of Texas M. D. Anderson Cancer Center report at the 49th annual meeting of the American Society of Hematology.
   Similar news · Read more »
   
3. Donors' health associated with risk of infection among recipients of corneal transplants
   02-11-2008 · EurekAlert!
   Corneal grafts obtained from donors dying in the hospital or with cancer may be associated with an increased risk of infection for the recipient, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
   Similar news · Read more »
   
4. A faster way to recover from chemotherapy and marrow transplant
   06-20-2007 · EurekAlert!
   Researchers at Children's Hospital Boston report finding a practical way to increase stem cells in blood, suggesting a possible treatment to help patients recover from chemotherapy or bone marrow transplant for cancer, regaining immune function more quickly. The discovery, reported in the June 21 Nature and made possible through high-volume drug screening in fish, marks the first time stem-cell production has been induced by a small-molecule drug.
   Similar news · Read more »
   
5. High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer
   12-13-2007 · EurekAlert!
   High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at the University of Texas M. D. Anderson Cancer Center.
   Similar news · Read more »
   
6. Cell phone use not linked to cancer risk
   12-05-2006 · EurekAlert!
   Long- or short-term cell phone use is not associated with increased cancer risk, according to a study in the Dec. 6 issue of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
7. Advanced therapy offers cure for relapsed cancer patient
   07-25-2007 · EurekAlert!
   Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine study by Lawrence Einhorn, M.D.; Stephen Williams, M.D.; Rafat Abonour, M.D., and colleagues published in the July 26 issue of the New England Journal of Medicine. Although the number of relapsed testicular cancer patients in the US is small, the IU Simon Cancer Center treats a majority of them.
   Similar news · Read more »
   
8. Isolation of a new gene family essential for early development
   08-22-2007 · EurekAlert!
   Researchers at BRIC, University of Copenhagen, have identified new gene family essential for embryonic development. The family controls the expression of genes crucial for stem cell differentiation, and the results may contribute significantly to the understanding of cancer development. The results are published in Nature, and it follows up on two other high-impact articles on related gene families published in Nature and Cell by the same researchers within the last year.
   Similar news · Read more »
   
9. New drug therapy to combat GVHD in stem-cell patients shows significant reduction in deaths
   01-23-2007 · EurekAlert!
   Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. Now, new research from Fred Hutchinson Cancer Research Center shows that adding a widely used topical corticosteroid to the standard treatment for GVHD kept the disease in remission and significantly reduces deaths one year after therapy.
   Similar news · Read more »
   
10. 'Mini transplant' patients' outcomes similar using related and unrelated donor cells
    12-03-2007 · EurekAlert!
    People who undergo nonmyeloablative stem-cell transplants, or 'mini transplants,' for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
    Similar news · Read more »